Work

Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma

Year: 2017

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.03.046

Authors: Shaji Kumar, Jonathan L. Kaufman, Joseph Mikhael, Cristina Gasparetto, Ravi Vij, Brigitte Pegourie, Lofti Benboubker, Thierry Facon, Philippe Moreau, Martine Amiot, Stefanie Alzate, Martin Dunbar, Tu Xu, Suresh Agarwal, Joel Leverson, Jeremy Ross, Paulo Maciag, Maria Verdugo, Cyrille Touzeau

Institutions: Mayo Clinic, Winship Cancer Institute, Mayo Clinic in Arizona, Duke University, Washington University in St. Louis, Hôpital Bretonneau, Hôpital Claude Huriez, Hôtel-Dieu de Paris, Centre Hospitalier Universitaire de Nantes, Nantes Université, AbbVie (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2605804754

FWCI:

Cites:

Cited by:

Related to: 10